Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.

Courses

2016 PHA's International PH Conference and Scientific Sessions Courses
2016 PHA's International PH Conference and Scientific Sessions Courses

PH Fundamentals 

  1. CTEPH: Surgical vs Medical Patient
  2. Imaging in PH: What Can a Picture Tell You?
    • John Ryan, M.D., FACC, FAHA
    • Course 
  3. Interesting and Challenging Cases in PH
    • Harrison Farber, M.D.
    • Course 
  4. Is It PAH or Not: Diagnostic Challenges
    • Ioana Preston, M.D., FACCP
    • Course 
  5. Management of PH in the ICU
  6. Pediatric Patients: How to Manage, How To Treat
    • Erika Rosenzweig, M.D.
    • Course
  7. PH Group III: Cases and Challenges
  8. Salvage Therapies in the U.S. and Europe versus Everywhere Else
    • Corey E. Ventetuolo, M.D., MS,  Tomas Pulido, M.D.
    • Course
  9. Therapies for PAH: Transitions and Case Examples
    • Martha Kingman, FNP-C, DNP
    • Course
  10. Transplanting in the PAH Patient: Screening and Evaluation for Lung Transplant
  11. Updated Algorithm of PAH Treatment: PHrontline News 
    • Mardi Gomberg-Maitland M.D., MSC
    • Course 

Scientific Sessions

  1. Etiologies of PH Across the World
    • Ghazwan Butrous, Ph.D., MB, ChB, FESC, FRSA
    • Course 
  2. From Bench to Bedside: Which Novel Pathways are Most Likely to Be Harnessed Therapeutically in the Next 25 Years?
    • Eric Austin, M.D., MSCI
    • Course
  3. Panel Discussion: Enhancing Access to Drugs in Developing Countries, Challenges of Making Generic Drugs Available in Developing Countries
    • Steven M. Kawut, M.D., MS, Mona Selej, M.D., MS, Ghazwan Butrous, MB, ChB, Ph.D., FESC, FRSA, Talant M. Sooronbaev, M.D.
    • Course 
  4. Rethinking Pediatric PH- International Aspects
    • Eric Austin, M.D., MSCI
    • Course 
  5. What Has Happened in the Last 25 Years: Global Perspectives/ 20 Years of Prostacyclins
    • Vallerie McLaughlin, M.D.
    • Course
  6. What Have We Learned From Worldwide Registries?

Oral Abstract Presentations (Non-accredited)

  1. PHD2 Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension Recapitulating Clinical PAH
    • Zhiyu Dai, Ph.D
  2. A Selective TGFβ Ligand Trap Attenuates Pulmonary Arterial Hypertension
    • Lai-Ming Yung, M.D.


Reviews

  Sign in to add a review

Comments